Showing results (561-570 of 673) with videos related to

Sort By:
Pageof 68
European Journal of Medicinal Chemistry|November 24, 2021
Identification of indole-based activators of insulin degrading enzymeNicolas Kraupner, Chau Phi Dinh, Xiaoan Wen, et al.
Nature Communications|February 9, 2026
Partitioned polygenic scores show mechanistic heterogeneity in type 2 diabetes and hypertension comorbidityVincent Pascat, Liudmila Zudina, Lucas Maurin, et al.
European Journal of Medicinal Chemistry|March 21, 2026
Discovery of pyrimidine-based small activators of insulin degrading enzymeJamal El Bakali, Cyril Ronco, Valérie Landry, et al.
Plos One|March 10, 2012
Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis developmentKristiaan Wouters, Céline Cudejko, Marion J J Gijbels, et al.
Diabetes, Obesity & Metabolism|March 21, 2020
Incretin combination therapy for the treatment of non-alcoholic steatohepatitisAimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, et al.
The Journal of Clinical Investigation|April 4, 2013
Hepatic glucose sensing is required to preserve β cell glucose competencePascal Seyer, David Vallois, Carole Poitry-Yamate, et al.
European Journal of Medicinal Chemistry|April 17, 2014
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysisJulie Charton, Marion Gauriot, Qing Guo, et al.
Pageof 68